A different approach to ecchymosis due to paroxetine

References (14)

1. Yüksel N (ed). Temel Psikofarmakoloji. Türkiye Psikiyatri Derneği, Ankara, 2010
2. Skop B, Brown T. Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors.Psychosomatics. 1996;37:12–6
3. Oyesanmi O, Kunkel EJ, Monti DA, Field HL. Hematologic side effects of psychotropics. Psychosomatics. 1999;40:414-21
4. Ay R. Paroksetin Kullanımı ile İlişkili Ekimoz: Bir Olgu Sunumu. Klinik Psikiyatri. 2017;20:243-6
5. Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9:47-59
6. Salvia-Roiges MD, Garcia L, Gonce-Mellgren A, Esque-Ruiz MT, Figueras-Aloy J, Carbonell-Estrany X. Neonatal convulsions and subarachnoid hemorrhage after in utero exposure to paroxetine. Rev Neurol. 2003;36:724-6
7. Meijer WE, Heerdink ER, Nolen WA, Herings RM, Leufkens HG, Egberts AC. Association of risk of abnormal bleeding with degree of serotonin reuptake inhibition by antidepressants. Arch Intern Med. 2004;164:2367–70
8. Hergovich N, Aigner M, Eichler HG, Entlicher J, Drucker C, Jilma B. Paroxetine decreases platelet serotonin storage and platelet function in human beings. Clin Pharmacol Ther. 2000;68:435-42. 9. de Abajo FJ, Montero D, Rodriguez LA, Madurga M. Antidepressants and risk of upper gastrointestinal bleeding. Basic Clin Pharmacol Toxicol. 2006;98:304- 10
9. Layton D, Clark DW, Pearce GL, Shakir SA. Is there an association between selective serotonin reuptake inhibitors and risk of abnormal bleeding? Results from a cohort study based on prescription event monitoring in England. Eur J Clin Pharmacol. 2001;57:167-76
10. Abdelmalik N, Ruhe HG, Barwari K, van den Dool EJ, Meijers JC, Middeldorp, S et al. Effect of the selective serotonin reuptake inhibitor paroxetine on platelet function is modified by a SLC6A4 serotonin transporter polymorphism. J Thromb Haemost. 2008;6:2168-74
11. Wgner A, Montero D, Martensson B, Siwers B, Asberg M. Effects of fluoxetine treatment of platelet 3H-imipramine binding, 5-HT uptake and 5-HT content in major depressive disorder. J Affect Disord. 1990;20:101-13
12. Siddiqui R, Gawande S, Shende T, Tadke R, Bhave S, Kirpekar V. SSRI-induced coagulopathy: is it reality? Ther Adv Psychopharmacol. 2011;1:169–74
13. Şaylan M, Tukel R. Bleeding attributed to the use of paroxetine. Klinik Psikofarmakoli Bult. 2005;15:79- 83
14. Blasco-Fontecilla H, de Leon J. Lower gastrointestinal bleeding and paroxetine use: two case reports. Psychosomatics. 2012;53: